Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pupillary Changes as Biomarker for Escitalopram
NCT00397059Phase 4Completed
- Sponsor
- University of Southern Denmark
- Start
- Dec 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and anxiety disorders comparing Escitalopram with Placebo (2 arms). Primary endpoints: Dynamic pupillometry, Pharmacokinetics and 1 more. Started Dec 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorders
Beyond the preview
Go deeper on NCT00397059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397059.